Related Experiment Video
Updated: Dec 27, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Effects of Nicotinamide on Cervical Cancer-Derived Fibroblasts: Evidence for Therapeutic Potential
Reem N Hassan1, Hualei Luo1, Weiying Jiang1
1Department of Medical Genetics, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong 510080, People's Republic of China.
Purpose:
The present study aimed to examine the effects of nicotinamide (NAM) on cervical cancer-associated fibroblasts (CAF) for its in vitro efficacy, gross inhibition, and mechanism of inhibition.
Methods:
The fibroblasts were treated with pre-specified concentrations of NAM followed by measurement of the cell proliferation using CCK-8 assay. The production of reactive oxygen species (ROS) was measured by 2',7'-Dichlorofluorescin diacetate. We further investigated the apoptosis by flow cytometry using Annexin-V. We employed JC-1 assay to detect changes in the potential of the mitochondrial membrane. We further determined the expression of apoptotic genes was measured using qRT-PCR. And lastly, cell cycle experiments were conducted to determine the influence of NAM on arresting the growth of CAF in a cell cycle.
Results:
Our study showed that NAM was able to reduce fibroblasts viability. We specifically observed a significantly increased intracellular ROS with resultant exhaustion of cellular antioxidant defense machinery, including reduced glutathione (GSH). We further observed the involvement of mitochondrial pathway in the NAM induced apoptosis of fibroblasts.
Conclusion:
Our study supports the therapeutic potential of NAM for the treatment of cervical cancer and necessitates a further investigation of the reported findings.
Insights
Nicotinamide (NAM) reduces cervical cancer-associated fibroblast (CAF) viability by increasing reactive oxygen species (ROS) and inducing apoptosis. This suggests NAM has therapeutic potential for cervical cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cervical cancer-associated fibroblasts (CAFs) play a crucial role in tumor progression.
- Understanding the mechanisms that inhibit CAF growth is essential for developing novel cancer therapies.
Purpose of the Study:
- To investigate the in vitro efficacy of nicotinamide (NAM) on cervical cancer-associated fibroblasts (CAFs).
- To elucidate the mechanism by which NAM inhibits CAF proliferation and induces apoptosis.
Main Methods:
- Cell viability was assessed using the CCK-8 assay.
- Reactive oxygen species (ROS) production was measured using 2',7'-Dichlorofluorescin diacetate.
- Apoptosis, mitochondrial membrane potential, and cell cycle arrest were analyzed by flow cytometry (Annexin-V, JC-1 assay) and qRT-PCR.
Main Results:
- Nicotinamide significantly reduced fibroblast viability.
- NAM treatment led to increased intracellular ROS and decreased glutathione (GSH) levels, indicating oxidative stress.
- Apoptosis was induced in fibroblasts via the mitochondrial pathway, with observed changes in apoptotic gene expression and cell cycle arrest.
Conclusions:
- Nicotinamide demonstrates therapeutic potential against cervical cancer-associated fibroblasts in vitro.
- The findings highlight NAM's ability to induce oxidative stress, apoptosis, and cell cycle arrest in CAFs.
- Further research is warranted to explore NAM's clinical application in cervical cancer treatment.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Related Concept Videos
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...